Please cite this paper as: Manchanda R, Abdelraheim A, Johnson M, Rosenthal A, Benjamin
E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon U …

Purpose Women who carry deleterious mutations of BRCA1 or BRCA2 genes have up to a
54% lifetime risk of developing ovarian cancer. After childbearing, women at high risk …

OBJECTIVE: To determine the prevalence, localisation and type of occult (non) invasive
cancer in risk-reducing salpingo-oophorectomy (RRSO) specimens in BRCA-mutation …

Background: Women carriers of BRCA mutations often have occult malignancy found at the
time of risk-reducing bilateral salpingo-oophorectomy (RRSO). We report outcomes in 111 …

Risk-reducing salpingo-oophorectomy (RRSO) is an effective prophylactic procedure for
women with mutations in BRCA1 or BRCA2 genes, both of which confer an increased …

OBJECTIVES: The reported incidence of neoplasia identified at the time of risk-reducing
salpingo-oophorectomy (RRSO) in germline BRCA1/2 mutation carriers ranges from 4 to …

OBJECTIVE: The purpose of this study was to define the rate of neoplasia in prophylactic
surgical specimens with the use of a careful surgical and pathologic protocol in a …

OBJECTIVE: The objective of this study was to evaluate clinical factors associated with
choosing prophylactic bilateral salpingo-oophorectomy (BSO) over surveillance in women …

Background Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to
carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their …

Background Risk-reducing salpingo-oophorectomy is often considered by carriers of BRCA
mutations who have completed childbearing. However, there are limited data supporting the …